Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
2.515
+0.010 (0.40%)
Jun 27, 2025, 4:25 PM CET
146.57%
Market Cap 877.70M
Revenue (ttm) n/a
Net Income (ttm) -42.21M
Shares Out 348.99M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,666,689
Average Volume 4,496,096
Open 2.470
Previous Close 2.505
Day's Range 2.465 - 2.550
52-Week Range 0.956 - 4.990
Beta n/a
RSI 48.78
Earnings Date Aug 29, 2025

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.